Trial intelligence / Profile preview

Synarel vs Progesterone for Luteal Phase Support in IVF

NCT05484193Unknown

Sponsor
Shaare Zedek Medical Center
Start
Jun 2020
Primary completion
Apr 2022
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of nafarelin in infertility (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Pregnancy Rate at 2 weeks. Status: unknown.

02

Drugs

nafarelin
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05484193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05484193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call